Ahmed Kotb, Adult Hematology and Bone Marrow Transplant Specialist at King Faisal Specialist Hospital International Holding Company, shared a post on X:
“ESMO 2025 – Stage III-IV DLBCL
PET+ test MYC ± BCL2
<80, fit:
- IPI <2 → 6x R-CHOP
- IPI ≥2 → 6x R-Pola-CHP
≥80 or unfit:
- Fit: R-miniCHOP
- Unfit: R-COMP / R-GCVP / R-CEOP
Consider ISRT for bulky/residual and CNS ppx if high-risk.”
More posts featuring DLBCL.